Show simple item record

dc.contributor.authorDoshi, Peter
dc.date.accessioned2018-08-15T11:34:13Z
dc.date.available2018-08-15T11:34:13Z
dc.date.issued2018-08-14
dc.identifier.citationDoshi, P. (2018) EMA scales back transparency initiatives because of workload. BMJ. 362:k3513. DOI: 10.1136/bmj.k3513en_US
dc.identifier.urihttp://hdl.handle.net/10713/8133
dc.descriptionPeter Doshi discusses recent changes to two of the EMA’s policies affecting access to its archives (policy 0043) and publication of new clinical data (policy 0070). The former is a permanent revision while the latter is temporary. Both policies reduce transparency by restricting access to drug data critical to independent research initiatives associated with safety, efficacy, and appropriate trial methodology.en_US
dc.description.urihttp://bmj.com/cgi/content/full/bmj.k3513?ijkey=XAqxutYhD4TBabt&keytype=refen_US
dc.language.isoen_USen_US
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectdata access policiesen_US
dc.subjectEMAen_US
dc.subjectpolicy 0043en_US
dc.subjectpolicy 0070en_US
dc.subject.lcshEuropean Medicines Agencyen_US
dc.subject.meshAccess to Informationen_US
dc.titleEMA scales back transparency initiatives because of workloaden_US
dc.typeArticleen_US
dc.description.urinameClick here for free full-text article on publisher's websiteen_US
refterms.dateFOA2019-02-19T18:34:50Z


Files in this item

Thumbnail
Name:
Doshi_EMAScalesBackTransparenc ...
Size:
818.1Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

https://creativecommons.org/licenses/by-nc-nd/4.0/
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by-nc-nd/4.0/